VolitionRx Ltd
VNRX
31 hedge funds and large institutions have $4.52M invested in VolitionRx Ltd in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 8 closing their positions.
900% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
11% more funds holding
Funds holding: 28 → 31 (+3)
9% more capital invested
Capital invested by funds: $4.13M → $4.52M (+$392K)
0.17% more ownership
Funds ownership: 0.66% → 0.83% (+0.17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$1.12M |
| 2 |
LM
Luminus Management
Houston,
Texas
|
+$238K |
| 3 |
State Street
Boston,
Massachusetts
|
+$88K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$63.5K |
| 5 |
WANY
Wealthspire Advisors (New York)
New York
|
+$52.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$42.9K |
| 2 |
Squarepoint
New York
|
-$34.4K |
| 3 |
Jane Street
New York
|
-$28.5K |
| 4 |
VF
Virtu Financial
New York
|
-$28K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$23.2K |
VNRX Hedge Fund Activity: Q1 2026 in Review
31 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2026, worth a combined $4.52M — up 9.5% from $4.13M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VNRX positions and 8 closed out — a net gain of 4 holders — while 10 added to existing stakes and 1 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $1.12M. The largest seller was Citadel Advisors, exiting entirely with an estimated $42.9K sold.
- 31 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2026, up from 28 in Q4 2025.
- Funds reported $4.52M of VolitionRx Ltd stock for Q1 2026, up 9.5% quarter-over-quarter.
- 12 funds opened new VolitionRx Ltd positions in Q1 2026 and 8 closed out, a net change of +4 holders.
- The largest VolitionRx Ltd buyer in Q1 2026 was Lagoda Investment Management, an estimated $1.12M added.
- The largest VolitionRx Ltd seller in Q1 2026 was Citadel Advisors, an estimated $42.9K sold.
Based on aggregated 13F filings for Q1 2026.